TABLE 2.
Patient condition | No. of samples reactive/no. of samples examined
|
|||||
---|---|---|---|---|---|---|
IgM
|
IgG
|
|||||
IFA | EIA | WB | IFA | EIA | WB | |
Systemic lupus erythematosus | 0/2 | 0/2 | 0/2 | 0/2 | 0/2 | 0/2 |
Rheumatoid factor | 0/5 | 1/5 | 0/5 | 0/7 | 0/7 | 0/5 |
Chronic fatigue syndrome | 0/5 | 0/5 | 0/5 | 1/5 | 0/5 | 0/5 |
Infectious mononucleosis | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 |
Group A streptococcal sequelae | 0/2 | 0/2 | 0/2 | 0/2 | 0/2 | 0/2 |
Relapsing fever | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 |
Syphilis | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
Human monocytic ehrlichiosis | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 |
Rocky Mountain spotted fever | 2/4 | 0/4 | 0/4 | 0/4 | 0/4 | 0/4 |
Q fever | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 | 0/1 |
All disorders | 2/53 | 1/31 | 0/31 | 1/53 | 0/46 | 0/31 |
Healthy donors | 0/32 | 1/169 | 0/30 | 0/32 | 2/169 | 0/30 |